Tumour-expressed tissue factor inhibits cellular cytotoxicity Chao LiLucy M. ColmanCamille Ettelaie Original Article 02 February 2006 Pages: 1301 - 1308
Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12 Chang-Hyun KimMin-Jung HongYong-Kil Hong Original Article 04 February 2006 Pages: 1309 - 1319
Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer Toru NakanishiKazuyoshi ImaizumiKaoru Shimokata Original Article 02 February 2006 Pages: 1320 - 1329
Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice Ali Abdul-HaiArie Ben-YehudaReuven Or Original Article 01 February 2006 Pages: 1330 - 1336
PankoMab: a potent new generation anti-tumour MUC1 antibody Antje DanielczykRenate StahnSteffen Goletz Original Article 17 February 2006 Pages: 1337 - 1347
Autologous control of a highly malignant syngeneic CRNK-16 leukemia in the rat: a role for NK cells Roi AvrahamShelly InbarShamgar Ben-Eliyahu Original Article 08 February 2006 Pages: 1348 - 1357
Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs Kousaku MimuraKoji KonoHideki Fujii Original Article 25 January 2006 Pages: 1358 - 1366
A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells P. WolfD. GierschnerU. Elsässer-Beile Original Article 18 March 2006 Pages: 1367 - 1373
Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphate Thomas PutzReinhold RamonerMartin Thurnher Original Article 17 February 2006 Pages: 1374 - 1383
Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells Cheryl L.-L. ChiangJonathan A. LedermannBenjamin M. Chain Original Article 04 February 2006 Pages: 1384 - 1395
Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI) Jan SchmidtEmilia M. PatrutAngela Märten Original Article 17 February 2006 Pages: 1396 - 1405
International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers Barbara-ann GuinnJames S. NorrisAlbert B. Deisseroth Symposium Paper 17 June 2006 Pages: 1406 - 1411
Targeted and shielded adenovectors for cancer therapy Susan J. HedleyJian ChenImre Kovesdi Symposium Paper 13 April 2006 Pages: 1412 - 1419
Virology- and immunology-based gene therapy for cancer Masatoshi TagawaKiyoko KawamuraTakenori Ochiai Symposium Paper 12 May 2006 Pages: 1420 - 1425
Immune enhancement and anti-tumour activity of IL-23 Jing-Sheng HaoBao-En Shan Symposium Paper 05 May 2006 Pages: 1426 - 1431
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells Jon A. KyteGustav Gaudernack Symposium Paper 13 April 2006 Pages: 1432 - 1442
Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic disease M. TangneyG. CaseyG. C. O’Sullivan Symposium Paper 13 April 2006 Pages: 1443 - 1450